Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization-Reference-Cited by-同舟云学术

Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization

Published:2017-07 Issue:7 Volume:23 Page:1151-1157
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Anand Sarah,Thomas Samantha,Hyslop Terry,Adcock Janet,Corbet Kelly,Gasparetto Cristina,Lopez Richard,Long Gwynn D.,Morris Ashley K.,Rizzieri David A.,Sullivan Keith M.,Sung Anthony D.,Sarantopoulos Stefanie,Chao Nelson J.,Horwitz Mitchell E.

Funder

National Institutes of Health (NIH)

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Umbilical cord blood transplantation: the first 25 years and beyond;Ballen;Blood,2013

2. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood;Brunstein;Blood,2010

3. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis;Eapen;Lancet Oncol,2010

4. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation;Parody;Biol Blood Marrow Transplant,2006

5. Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources;Ballen;Biol Blood Marrow Transplant,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of co-transplantation of umbilical cord blood and third-party mesenchymal stromal cells after (non)myeloablative conditioning in patients with hematological malignancies;Current Research in Translational Medicine;2024-12

2. Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético);Transplantation and Cellular Therapy;2024-07

3. The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients;Expert Opinion on Biological Therapy;2024-03-03

4. Omidubicel: First Approval;Molecular Diagnosis & Therapy;2023-06-24

5. Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies;Transplantation and Cellular Therapy;2023-02